Is FDS a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for FactSet Research Systems (FDS) rests on Recurring ASV re-acceleration: FactSet's organic ASV reached about $2.49 billion in fiscal Q3 2026, up roughly 7.1% year over year, an acceleration from around 6.7% the prior quarter. Revenue (TTM) is ~$2.44B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: The biggest concern is margin pressure: adjusted operating margin fell roughly 300 basis points year over year to around 34% as FactSet spends heavily on AI, cloud, and product, and GAAP profitability has narrowed. Whether FDS is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
FactSet Research Systems sells a subscription-based platform of financial data, analytics, and workflow tools to investment banks, asset managers, wealth managers, hedge funds, and corporate clients. Its core metric is Annual Subscription Value (ASV), the annualized value of client subscriptions, which makes revenue highly recurring and predictable. The product spans data feeds, portfolio analytics, research management, and increasingly AI-assisted tools that sit inside the daily workflow of analysts and portfolio managers. High retention and multi-year client relationships give the business a wide, sticky moat, though it competes against much larger data vendors. The investment picture is a story of a quality compounder that has slowed and derated. Organic ASV growth cooled from double digits after the 2021-2022 boom into the mid-single digits, and the stock fell well off its 2024 highs into 2026 even as ASV growth re-accelerated back toward 7%. Adjusted operating margin has compressed as management invests heavily in AI, cloud infrastructure, and product, and the shares now trade at a much lower earnings multiple than their historical premium. For investors, FDS offers a resilient, cash-generative subscription model with steady buybacks and a growing dividend, set against slower growth and questions about how AI reshapes demand for financial data.
What's the case for buying FDS?
1. Recurring ASV re-acceleration
FactSet's organic ASV reached about $2.49 billion in fiscal Q3 2026, up roughly 7.1% year over year, an acceleration from around 6.7% the prior quarter. Because nearly all revenue is subscription based, ASV growth translates fairly directly into future revenue. Continued re-acceleration is the central bull argument after several years of slowing growth.
2. AI-integrated workflow products
Management is embedding generative AI across the platform, including conversational research tools and AI-assisted analytics, aiming to deepen usage and justify pricing. The pitch is that AI makes FactSet's proprietary and licensed data more valuable inside client workflows rather than commoditizing it. Execution here is a key driver of both growth and the competitive response to larger rivals.
3. High retention and pricing power
FactSet reports strong client and ASV retention, reflecting how embedded its tools are in daily investment workflows. Sticky, multi-year relationships support steady price increases and expansion within existing accounts. This durability is what has historically earned the stock a premium multiple.
4. Cash generation and capital returns
The business converts a high share of earnings into free cash flow, about $254 million in fiscal Q3 2026, up roughly 11% year over year. Management returns capital through a consistently growing dividend and share repurchases. Strong cash flow funds both AI investment and shareholder returns while keeping leverage manageable.
What are the risks to FDS?
The biggest concern is margin pressure: adjusted operating margin fell roughly 300 basis points year over year to around 34% as FactSet spends heavily on AI, cloud, and product, and GAAP profitability has narrowed. Growth is only mid-single digits, far below the double-digit pace of a few years ago, and the stock derated sharply from its 2024 highs as a result. Competition is intense and comes from much larger players, including Bloomberg, LSEG (Refinitiv), S&P Global, and Moody's, some with deeper resources for AI and data. There is also a longer-term question of whether generative AI compresses demand for traditional financial-data terminals. A slowdown in financial-industry hiring or budgets would directly pressure ASV growth.
How is FDS valued? (as of JULY 2026)
Snapshot for FDS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$2.44B
- Q3 FY2026 revenue: ~$622.9M (+6.4% YoY, organic +7.0%)
- Organic ASV: ~$2.49B (+7.1% YoY)
- Adjusted diluted EPS (Q3 FY2026): ~$4.53 (+6.1% YoY)
- FY2026 adjusted EPS guidance: ~$17.25 to $17.75
- Market cap: ~$8.8B
FactSet reaffirmed fiscal 2026 guidance of roughly $2.45 to $2.47 billion in revenue, adjusted operating margin of 34.0% to 35.5%, and adjusted diluted EPS of about $17.25 to $17.75. The stock traded near $247 in mid-July 2026, well below its 2024 highs above $450, putting the trailing earnings multiple in the mid-teens, near multi-year lows for the name and a sharp compression from its historical premium. Investors are effectively paying much less for FactSet's steady subscription growth than they did a couple of years ago.
How do you decide if FDS is a buy?
Rather than asking whether FDS is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold FDS indirectly through an index or sector ETF before adding more.
For the full picture, see the FDS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about FDS against your real portfolio and see your actual exposure before deciding.
The bottom line on FDS
The bottom line: FactSet Research Systems's story right now is Recurring ASV re-acceleration, with revenue (ttm) at ~$2.44B. If you believe that narrative continues, the call is about sizing FDS sensibly and checking overlap with what you own; if you doubt it (the risk: the biggest concern is margin pressure: adjusted operating margin fell roughly 300 basis points year over year to around 34% as FactSet spends heavily on AI, cloud, and product, and GAAP profitability has narrowed.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around FDS with Walnut
Use FactSet Research Systems as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is FDS a good stock to buy right now?
+
The case for FactSet Research Systems right now is Recurring ASV re-acceleration, with revenue (ttm) at ~$2.44B. If you believe that thesis holds, FDS is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is the biggest concern is margin pressure: adjusted operating margin fell roughly 300 basis points year over year to around 34% as FactSet spends heavily on AI, cloud, and product, and GAAP profitability has narrowed. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does FactSet Research Systems do?
+
FactSet Research Systems sells a subscription-based platform of financial data, analytics, and workflow tools to investment banks, asset managers, wealth managers, hedge funds, and
What are the main risks of FDS?
+
The biggest concern is margin pressure: adjusted operating margin fell roughly 300 basis points year over year to around 34% as FactSet spends heavily on AI, cloud, and product, and GAAP profitability has narrowed. Growth is only mid-single digits, far below the double-digit pace of a few years ago, and the stock derated sharply from its 2024 highs as a result. Competition is intense and comes from much larger players, including Bloomberg, LSEG (Refinitiv), S&P Global, and Moody's, some with deeper resources for AI and data. There is also a longer-term question of whether generative AI compresses demand for traditional financial-data terminals. A slowdown in financial-industry hiring or budgets would directly pressure ASV growth.
What does FactSet do?
+
FactSet Research Systems sells a subscription platform of financial data, analytics, and workflow tools to investment banks, asset and wealth managers, hedge funds, and corporations. Its products help analysts and portfolio managers research securities, build portfolios, and manage data inside their daily workflows.
Is FDS profitable?
+
Yes. FactSet is consistently profitable and highly cash generative, reporting adjusted diluted EPS of about $4.53 in fiscal Q3 2026 and roughly $254 million of free cash flow that quarter. Its adjusted operating margin runs around 34%, though margins have compressed as it invests in AI and technology.
What is ASV and why does it matter for FactSet?
+
ASV, or Annual Subscription Value, is the annualized value of FactSet's client subscriptions and its most-watched growth metric. Because nearly all revenue is recurring, ASV growth signals future revenue. Organic ASV reached about $2.49 billion in fiscal Q3 2026, up roughly 7.1% year over year.
Why has FDS stock fallen so much?
+
FactSet's shares dropped from above $450 in 2024 to around $247 by mid-July 2026 as growth slowed to the mid-single digits and margins compressed under heavy AI and technology spending. The premium valuation the market once assigned the name contracted toward multi-year lows during the decline.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell FDS; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.